MDxHealth SA, the Belgian molecular diagnostics company, is intending to raise at least €6 million with a private placement of its shares managed jointly by Kempen & Co and Nomura Code Securities. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
